Gilead Tenofovir Cases, Gilead Sciences v. Superior Court of the City and County of San Francisco

California

(Ca., filed November 4, 2024): Arguing that the novel duty to innovate recognized by the Court of Appeal would flood the judiciary and burden manufacturers with a large number of speculative lawsuits and would undermine the predictability of product liability law.  Additionally, the new duty would result in price increases as manufacturers tried to estimate the magnitude of their potential liability and would slow the pace of innovation and undermine safety in the name of promoting it.

Share This Post:
The American Tort Reform Association is the nation’s first organization dedicated exclusively to reforming the civil justice system through education and legislative enactment.

To receive occasional updates from ATRA, enter your email address:
By subscribing, you agree to our Privacy Policy and consent to receive updates.
© 2026 ATRA. All rights reserved.